I think this AIM-listed tech stock is beginning to fulfil its potential

Blue Prism is an RPA specialist that has just revealed a chunky loss. But look closer, I think it’s misunderstood by the markets.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Blue Prism (LSE: PRSM) is a company operating in the intelligent automation, or robotic process automation (RPA), space. It has just revealed a chunky loss but if we look closer, I think it’s misunderstood by the markets.

It all boils down to recurring revenue and to illustrate that, I’ll use  an analogy with an old-fashioned life assurance salesperson. It might take a lot to secure a new customer, but once that’s achieved, the salesperson can enjoy the commission for years. Blue Prism has been spending a lot on marketing, that’s the main reason why 2019 saw a big loss. But the revenue that will accrue from new business acquisition could continue for years.

Blue Prism invented the acronym RPA that actually has very little to do with what most of us think of when we hear the word robot. RPA is actually about software and automating tasks, often mind-numbingly dull tasks, often carried out in process-driven organisations such as banks or insurance companies.

RPA has been subject to enormous hype and some backlash too. It’s not necessarily easy for a company to start on its RPA journey, and maybe some RPA companies have promoted the technology too hard, exaggerating its ease of use, creating a degree of disillusionment.

There’s even talk that the RPA industry may actually ditch the acronym altogether to focus on intelligent automation.

Hype?

Blue Prism is the only one of the three major RPA companies to be listed on the stock market. The other two (UiPath and Automation Anywhere) have collectively raised well over a billion dollars.

Such massive fund raising is seen by some as evidence of hype, but it also illustrates how there’s something exciting about the technology in the first place.

It could certainly transform productivity at many companies. Some fear resulting job losses, but the RPA companies themselves talk about freeing staff from soul-destroying tedium.

Blue Prism’s results for the year to the end of October 2019 revealed an 83% increase in revenues to £101m, but its losses before interest, tax, depreciation and amortisation (EBITDA) were £71.9m. Then again, it had £74.1m in net cash at the end of the period. 

A loss of that scale might seem worrisome, but bear in mind the long-term benefits from its marketing spend. Monthly recurring revenue (MMR) rose to £10.6m, up roughly two-thirds from the year before.

Part of the loss was also explained by the purchase of another company in this space, Thoughtonomy, giving Blue Prism a stronger cloud presence.

What I like about RPA is that the ‘barriers to exit’ are quite low. Once a company is using a particular system, there’s a good chance it will stay with it. Certainly, client retention rates in this space are very high.

The Blue Prism customer count increased from 992 to 1,677 last year. New clients included Audi, Amazon, Bank of China, Consolidated Edison, the International Monetary Fund, L’Oréal and the United States Department of Justice.

The company expects to upsell its product to many of its customers, and it’s this scaling up of the technology within companies that provides the real opportunity to increase sales at a relatively modest cost. This is the reason why I think Blue Prism shares will go up, eventually.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Michael Baxter has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »